The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
Background: The mechanisms of Parkinson's disease (PD) include complicated genetic factors. The roles of newly found risk genes need to be further verified among different ethnicities. In a two-stage meta-analysis, single nucleotide polymorphism (SNP) of rs156429 in glycoprotein non-metastatic...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00952/full |
_version_ | 1819141387786911744 |
---|---|
author | Jin Liu Gen Li Yixi He Guiying He Pingchen Zhang Xin Shen Weishan Zhang Shengdi Chen Shishuang Cui Yuyan Tan |
author_facet | Jin Liu Gen Li Yixi He Guiying He Pingchen Zhang Xin Shen Weishan Zhang Shengdi Chen Shishuang Cui Yuyan Tan |
author_sort | Jin Liu |
collection | DOAJ |
description | Background: The mechanisms of Parkinson's disease (PD) include complicated genetic factors. The roles of newly found risk genes need to be further verified among different ethnicities. In a two-stage meta-analysis, single nucleotide polymorphism (SNP) of rs156429 in glycoprotein non-metastatic melanoma protein B (GPNMB) was reported to be associated with PD. So far clinical studies have focused on association between rs156429 and PD onset, however there is little evidence linking rs156429 with PD symptoms.Objective: This study aimed to investigate the possible association of GPNMB rs156429 with PD manifestations among southeastern Chinese people.Methods: Demographic variables, disease-related factors, and motor and non-motor assessments of 511 PD patients were collected. Polymerase chain reaction (PCR) and SNaPshot technique were used to detect GPNMB rs156429. The associations of rs156429 with PD rating scales and clinical manifestations were analyzed by Kruskal-Wallis test and logistic regression model separately.Results: Kruskal-Wallis test and logistic regression model failed to reveal an association between GPNMB rs156429 and scores from Montreal Cognitive Assessment (MoCA) (p = 0.037; p = 1.000 after correction), and pain symptoms of 511 PD patients (p = 0.008, OR = 0.59, 95% CI = 0.40–0.87, overdominant model after adjustment; p = 0.168 after correction, overdominant model after adjustment). However, further analysis based on genders showed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction (Mini-Mental State Examination (MMSE), p = 0.064 after correction; MoCA, p = 0.064 after correction) and pain symptoms (p = 0.063 after correction, overdominant model after adjustment) in female PD patients but not male patients.Conclusions: This study revealed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction and pain symptoms of female PD patients in the southeastern Chinese population. Further studies from a larger sample size are needed to confirm these findings. |
first_indexed | 2024-12-22T11:53:39Z |
format | Article |
id | doaj.art-ae757976932a40a6baee275ad8757f32 |
institution | Directory Open Access Journal |
issn | 1664-8021 |
language | English |
last_indexed | 2024-12-22T11:53:39Z |
publishDate | 2020-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Genetics |
spelling | doaj.art-ae757976932a40a6baee275ad8757f322022-12-21T18:26:55ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-09-011110.3389/fgene.2020.00952540334The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's DiseaseJin Liu0Gen Li1Yixi He2Guiying He3Pingchen Zhang4Xin Shen5Weishan Zhang6Shengdi Chen7Shishuang Cui8Yuyan Tan9Department of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Geriatrics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBackground: The mechanisms of Parkinson's disease (PD) include complicated genetic factors. The roles of newly found risk genes need to be further verified among different ethnicities. In a two-stage meta-analysis, single nucleotide polymorphism (SNP) of rs156429 in glycoprotein non-metastatic melanoma protein B (GPNMB) was reported to be associated with PD. So far clinical studies have focused on association between rs156429 and PD onset, however there is little evidence linking rs156429 with PD symptoms.Objective: This study aimed to investigate the possible association of GPNMB rs156429 with PD manifestations among southeastern Chinese people.Methods: Demographic variables, disease-related factors, and motor and non-motor assessments of 511 PD patients were collected. Polymerase chain reaction (PCR) and SNaPshot technique were used to detect GPNMB rs156429. The associations of rs156429 with PD rating scales and clinical manifestations were analyzed by Kruskal-Wallis test and logistic regression model separately.Results: Kruskal-Wallis test and logistic regression model failed to reveal an association between GPNMB rs156429 and scores from Montreal Cognitive Assessment (MoCA) (p = 0.037; p = 1.000 after correction), and pain symptoms of 511 PD patients (p = 0.008, OR = 0.59, 95% CI = 0.40–0.87, overdominant model after adjustment; p = 0.168 after correction, overdominant model after adjustment). However, further analysis based on genders showed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction (Mini-Mental State Examination (MMSE), p = 0.064 after correction; MoCA, p = 0.064 after correction) and pain symptoms (p = 0.063 after correction, overdominant model after adjustment) in female PD patients but not male patients.Conclusions: This study revealed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction and pain symptoms of female PD patients in the southeastern Chinese population. Further studies from a larger sample size are needed to confirm these findings.https://www.frontiersin.org/article/10.3389/fgene.2020.00952/fullParkinson's diseasesingle nucleotide polymorphismsGPNMBgeneticsclinical manifestation |
spellingShingle | Jin Liu Gen Li Yixi He Guiying He Pingchen Zhang Xin Shen Weishan Zhang Shengdi Chen Shishuang Cui Yuyan Tan The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease Frontiers in Genetics Parkinson's disease single nucleotide polymorphisms GPNMB genetics clinical manifestation |
title | The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease |
title_full | The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease |
title_fullStr | The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease |
title_full_unstemmed | The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease |
title_short | The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease |
title_sort | association analysis of gpnmb rs156429 with clinical manifestations in chinese population with parkinson s disease |
topic | Parkinson's disease single nucleotide polymorphisms GPNMB genetics clinical manifestation |
url | https://www.frontiersin.org/article/10.3389/fgene.2020.00952/full |
work_keys_str_mv | AT jinliu theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT genli theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT yixihe theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT guiyinghe theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT pingchenzhang theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT xinshen theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT weishanzhang theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT shengdichen theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT shishuangcui theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT yuyantan theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT jinliu associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT genli associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT yixihe associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT guiyinghe associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT pingchenzhang associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT xinshen associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT weishanzhang associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT shengdichen associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT shishuangcui associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease AT yuyantan associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease |